Anne S Tsao

Anne S Tsao

UNVERIFIED PROFILE

Are you Anne S Tsao?   Register this Author

Register author
Anne S Tsao

Anne S Tsao

Publications by authors named "Anne S Tsao"

Are you Anne S Tsao?   Register this Author

74Publications

1642Reads

49Profile Views

Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.

J Thorac Cardiovasc Surg 2019 Sep 16;158(3):924-929. Epub 2019 Apr 16.

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2019.02.129DOI Listing
September 2019

Use of Immune Checkpoint Inhibitors in Mesothelioma.

Curr Treat Options Oncol 2019 Feb 14;20(2):18. Epub 2019 Feb 14.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd. Unit 432, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0613-x
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0613-xDOI Listing
February 2019

Updates in Local-Regionally Advanced Non-Small Cell Lung Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:553-562. Epub 2019 May 17.

3 Division of Thoracic Surgery, Ronald Reagan UCLA Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
https://ascopubs.org/doi/10.1200/EDBK_237839
Publisher Site
http://dx.doi.org/10.1200/EDBK_237839DOI Listing
January 2019

Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

J Thorac Oncol 2018 09;13(9):1269-1283

Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643278PMC
September 2018

Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): A Step Forward in a Long Race.

J Thorac Oncol 2018 07;13(7):871-873

Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183060
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.05.003DOI Listing
July 2018

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

Eur J Cardiothorac Surg 2018 05;53(5):960-966

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezx427DOI Listing
May 2018

Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.

J Thorac Oncol 2018 02 5;13(2):246-257. Epub 2017 Dec 5.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.033DOI Listing
February 2018

A research protocol for a pilot randomized controlled trial designed to examine the feasibility of a couple-based mind-body intervention for patients with metastatic lung cancer and their partners.

Pilot Feasibility Stud 2018 24;4:37. Epub 2018 Jan 24.

1Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Unit 1414, 1515 Holcombe Boulevard, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40814-018-0231-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784695PMC
January 2018

Competitive Funding Strategies for the Conquer Cancer Foundation of ASCO.

J Oncol Pract 2017 01 22;13(1):e62-e67. Epub 2016 Nov 22.

Mayo Clinic, Phoenix, AZ; Albert Einstein College of Medicine, Bronx, NY; American Society of Clinical Oncology, Alexandria, VA; Aurora Health Care, Milwaukee, WI; and The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.014571DOI Listing
January 2017

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Oct;34(30):3638-3647

Vassiliki Papadimitrakopoulou, J. Jack Lee, Ignacio I. Wistuba, Anne S. Tsao, Frank V. Fossella, Neda Kalhor, Sanjay Gupta, Lauren Averett Byers, Julie G. Izzo, Ximing Tang, Ferdinandos Skoulidis, Don L. Gibbons, Li Shen, Caimiao Wei, Lixia Diao, S. Andrew Peng, Jing Wang, Alda L. Tam, John V. Heymach, and Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, TX; Scott N. Gettinger, Sarah B. Goldberg, Ja Seok Koo, and Roy S. Herbst, Yale University, New Haven, CT; Vincent A. Miller, Foundation Medicine, Cambridge, MA; Kevin R. Coombes, Ohio State University College of Medicine, Columbus, OH; and David J. Mauro and Eric H. Rubin, Merck, North Wales, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065110PMC
October 2016

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

J Clin Oncol 2016 08 20;34(23):2761-8. Epub 2016 Jun 20.

Andreas Rimner, Marjorie G. Zauderer, Prasad S. Adusumilli, Preeti K. Parhar, Abraham J. Wu, Kaitlin M. Woo, Ronglai Shen, Michelle S. Ginsberg, Ellen D. Yorke, Kenneth E. Rosenzweig, Valerie W. Rusch, and Lee M. Krug, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY; and Daniel R. Gomez, David C. Rice, and Anne S. Tsao, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019761PMC
August 2016

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners.

Infect Agent Cancer 2016 27;11:21. Epub 2016 Apr 27.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13027-016-0066-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847345PMC
April 2016

Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.

Clin Lung Cancer 2016 Mar 17;17(2):e5-11. Epub 2015 Nov 17.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304150026
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2015.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119523PMC
March 2016

Current readings: Window-of-opportunity trials for thoracic malignancies.

Authors:
Anne S Tsao

Semin Thorac Cardiovasc Surg 2014 24;26(4):323-30. Epub 2014 Dec 24.

Department of Thoracic & Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semtcvs.2014.12.005DOI Listing
January 2016

SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).

J Thorac Oncol 2015 Feb;10(2):387-91

*Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA; †SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; ‡Department of Medicine, Arizona Cancer Center, University of Arizona Tucson School of Medicine, Tucson, AZ; §Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA; ║Fox Chase Cancer Center, Philadelphia, PA; ¶Department of Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and #Department of Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304604PMC
February 2015

Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.

Int J Radiat Oncol Biol Phys 2015 Jan 25;91(1):149-56. Epub 2014 Oct 25.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.08.343DOI Listing
January 2015

Local and systemic therapies for malignant pleural mesothelioma.

Curr Treat Options Oncol 2014 Dec;15(4):683-99

Department of Thoracic Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-014-0314-4DOI Listing
December 2014

Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.

Ann Diagn Pathol 2014 Jun 20;18(3):140-5. Epub 2014 Feb 20.

Department of Thoracic and Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2014.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136493PMC
June 2014

Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.

Clin Lung Cancer 2014 May 27;15(3):197-201. Epub 2013 Dec 27.

Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080907PMC
http://dx.doi.org/10.1016/j.cllc.2013.12.008DOI Listing
May 2014

Immunotherapy in lung cancer.

Transl Lung Cancer Res 2014 Feb;3(1):53-63

1 Department of Thoracic Head and Neck Medical Oncology, 2 Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.01.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367607PMC
February 2014

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial.

Clin Cancer Res 2013 Dec 28;19(24):6967-75. Epub 2013 Oct 28.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905243PMC
December 2013

The importance of molecular profiling in predicting response to epidermal growth factor receptor family inhibitors in non-small-cell lung cancer: focus on clinical trial results.

Clin Lung Cancer 2013 Jul 11;14(4):311-21. Epub 2013 Apr 11.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.01.001DOI Listing
July 2013

Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment.

J Thorac Oncol 2013 Feb;8(2):e19-20

Department of Investigational Cancer Therapeutics (phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153275
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31827ce38eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551245PMC
February 2013

Mesothelioma.

Authors:
Anne S Tsao

J Thorac Oncol 2012 Dec;7(16 Suppl 5):S399-400

University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826df254DOI Listing
December 2012

Mitotic inhibitors.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1789-90

Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000407559.84157.c6DOI Listing
November 2011

Mesothelioma and small cell lung cancer.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1825-6

Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000407574.52702.92DOI Listing
November 2011

The future of NSCLC: molecular profiles guiding treatment decisions.

Oncology (Williston Park) 2011 Jun;25(7):607, 614

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
June 2011

A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria.

J Thorac Oncol 2011 Mar;6(3):598-601

Department of Thoracic and Head & Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318208c83dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643692PMC
March 2011

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Head Neck Oncol 2010 Jun 29;2:15. Epub 2010 Jun 29.

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://headandneckoncology.biomedcentral.com/articles/10.118
Publisher Site
http://dx.doi.org/10.1186/1758-3284-2-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908081PMC
June 2010

Surgery: Future directions in multimodality therapy for NSCLC.

Nat Rev Clin Oncol 2010 Jan;7(1):10-2

Department of Thoracic and Head & Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.174DOI Listing
January 2010

Radiotherapy in malignant pleural mesothelioma.

Int J Radiat Oncol Biol Phys 2009 Oct;75(2):326-37

Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.06.037DOI Listing
October 2009

Malignant pleural mesothelioma.

J Clin Oncol 2009 Apr 2;27(12):2081-90. Epub 2009 Mar 2.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.8523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881753PMC
April 2009

Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.

Clin Lung Cancer 2009 Jan;10(1):36-41

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.n.005DOI Listing
January 2009

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Mol Cancer Ther 2007 Jul;6(7):1962-72

Department of Thoracic/Head and Neck Medical Oncology, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0052DOI Listing
July 2007

Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Cancer 2006 Jun;106(11):2428-36

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21884DOI Listing
June 2006

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

J Thorac Oncol 2006 Mar;1(3):231-9

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1556-0864(15)31573-2DOI Listing
March 2006

Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Ann Thorac Surg 2005 Dec;80(6):1988-92; discussion 1992-3

Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2005.06.014DOI Listing
December 2005

Chemoprevention of cancer.

CA Cancer J Clin 2004 May-Jun;54(3):150-80

Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/canjclin.54.3.150DOI Listing
June 2004

Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.

Cancer 2004 May;100(10):2240-5

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20238DOI Listing
May 2004

C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome.

Leuk Res 2004 Apr;28(4):373-8

MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, P.O. Box 428 Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2003.09.008DOI Listing
April 2004

Imatinib mesylate causes hypopigmentation in the skin.

Cancer 2003 Dec;98(11):2483-7

Medical Oncology Fellowship Program, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11812DOI Listing
December 2003

Nonsmall-cell lung cancer: chemoprevention studies.

Semin Thorac Cardiovasc Surg 2003 Oct;15(4):405-20

MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/s1043-0679(03)00100-xDOI Listing
October 2003

Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.

Cancer Epidemiol Biomarkers Prev 2003 Jul;12(7):660-4

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
July 2003

STI-571 in chronic myelogenous leukaemia.

Br J Haematol 2002 Oct;119(1):15-24

Department of Bioimmunotherapy, M D Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03899.xDOI Listing
October 2002